Researchers have discovered that cytomegalovirus activates the immune system to continually feed sentinel cells into mucous membranes, offering better and more immediate protection. This finding suggests a strong candidate for vaccines against various pathogens, including HIV and tuberculosis.
A new study reveals the role of ephrin-B3 in organizing synapses, which is essential for healthy brain function. The discovery could lead to better treatments for neurological diseases such as autism and Alzheimer's.
A new study shows that half-matched donor bone marrow transplants can produce similar outcomes to full-match transplants, offering an alternative donor source for minorities and those without access to full matches. The Two-Step protocol used in the study may be a key factor in its success.
Researchers at Thomas Jefferson University found that arterial blood contains a higher number of circulating tumor cells (CTCs) than venous blood in uveal melanoma patients. This discovery raises concerns about the effectiveness of current detection techniques, which often rely on venous blood samples.
Researchers at Thomas Jefferson University found that patients with metastatic cancer are at high risk of venous thromboembolism after surgery, and a personalized approach to anticoagulation therapy is needed. The study suggests that the primary type of cancer may play a role in determining the risk for blood clots.
A recent study published in the Journal of Geriatric Oncology found that 26% of senior oncology patients use complementary or alternative medicines, which can interact with cancer treatments. The study highlights the need for comprehensive screening and documentation of CAM use in older cancer patients.
Researchers identified a subset of genes known as biomarkers that define a genomic subtype of prostate cancer more common in African American men. This subtype signals a more aggressive disease and is defined by the absence or low levels of three genes: ERG, ETS, and SPINK1.
A clinical pathway identified sleep disordered breathing in 87% of hospitalized patients, highlighting the need for early diagnosis and intervention to reduce cardiovascular complications. The low-cost protocol used a simple device, which correlated well with polysomnography, increasing awareness among admitting physicians.
Researchers at Thomas Jefferson University discovered DNA-PKcs as a central regulator of metastatic processes in prostate cancer. The kinase modulates signaling networks that turn on metastatic processes, and its levels can predict poor outcomes in patients. A potential drug inhibitor, CC-115, is currently being tested in clinical trials.
Researchers discovered a new category of tRNA fragments that depend on individual characteristics, including race, gender, and population. The analysis also found that tRNA fragments have regulatory roles in cellular processes and differ between tissues, disease subtypes, and individuals.
Researchers have discovered a new species of tRNA-derived small RNAs, called SHOT-RNAs, that contribute to cell proliferation in hormone-dependent breast and prostate cancers. These findings suggest a new role for tRNAs and potential therapeutic applications for the treatment of these cancers.
Researchers found that stress hormones, including glucocorticoids used to treat chemotherapy side effects, can stimulate growth of breast cancer cells resistant to anti-estrogen therapy. However, adding prolactin may prevent this expansion, offering a potential countermeasure.
Scientists at Thomas Jefferson University have identified two new genes, taranis and Cyclin-dependent kinase 1 (Cdk1), as crucial for regulating normal sleep patterns in flies. The researchers found that these genes interact with other proteins to create a molecular machine that suppresses wakefulness and promotes sleep.
Researchers at Thomas Jefferson University found that obese patients are more prone to developing acute respiratory distress syndrome (ARDS) due to a hormone imbalance. The study suggests that replacing the deficient hormone adiponectin may prevent ARDS in at-risk individuals.
The PALOMA-3 study found that palbociclib significantly extended progression-free survival for women with hormone-receptor-positive metastatic breast cancer, reducing cancer recurrence by 25% compared to chemotherapy alone. The treatment was well-tolerated and improved quality of life, offering a new hope for women with advanced disease.
A green dye called TAPP can kill bacteria on bone fragments and break up biofilms when exposed to light, reducing the risk of infections during reconstructive surgery. The study found that the dye binds tightly to bone without leaching out into surrounding fluid, suggesting a safe and non-toxic application.
A study confirms that GM-CSF drives inflammation and neuronal damage in MS, explaining why INF-Beta is effective at reducing MS attacks. The cytokine is also identified as a potential target for new therapies.
A new analysis found no link between induction of labor at full term and rates of C section in uncomplicated pregnancies. Induction was associated with slightly less blood loss and lower risk of meconium staining, but birth weight was lower in induced babies by 136 grams.
A new study found that 44% of adults with sickle cell disease experience sleep disordered breathing, which lowers oxygen levels at night. The study suggests screening for sleep disturbances using a questionnaire or oxygen desaturation index to identify potential risks in this population.
A new study evaluates currently available screening tools for senior cancer patients taking too many medications. It found that a more comprehensive assessment and monitoring plan is needed to improve treatment outcomes.
Despite pre-surgery antibiotics, bacterial clumps persist in joint fluid, forming protective mesh of proteins that slow growth and make them resistant to treatment. The study identified a key reason for the difficulty in curing joint infections: biofilm-like clumps of bacteria that harbor antibiotic-resistant superbugs.
Researchers have discovered nearly 3,400 new microRNA-generating loci in the human genome, more than tripling existing numbers. The newly found miRNAs are tissue- and human-specific, with significant implications for understanding disease causes.
Researchers found a genomic marker that could help identify patients most likely to benefit from cabazitaxel, a newer member of the taxane family. The study suggests that cabazitaxel may be more effective sooner in treatment for some patients with prostate cancer.
A study published in the Journal of Immunology found that infusing memory cells can produce and repeatedly replenish all of the T-effector cells needed to fight CMV infection. This approach may improve on current therapeutic options for controlling CMV infection, which affects up to 80% of adults in the US.
Women undergoing left-side breast cancer radiation therapy can reduce heart exposure by holding their breath, resulting in a 90% disease-free survival rate and a median reduction of 62% in radiation dose. The breath-hold technique also shows a lower risk of ischemic heart disease after 8 years.
Researchers found that SIRT1 enzyme loss drives early prostate cancer formation in mouse models. The study suggests SIRT1 may be a target for prostate cancer prevention.
Researchers uncover that C9orf72 gene mutation generates toxic PR protein causing brain damage in ALS, leading to motor neuron death. This discovery may lead to new treatments by preventing or breaking down PR aggregates.
Researchers have found that blocking the CCR5 receptor with an HIV drug can significantly reduce metastasis to the bone in prostate cancer. This breakthrough suggests a potential new treatment approach for patients with advanced prostate cancer.
Researchers discovered that excess lipids in the lungs trigger an inflammatory response, leading to scarring and pulmonary fibrosis. The team's findings suggest a new direction for developing novel therapies by targeting lipid handling in the lungs.
Researchers have uncovered a mechanism that explains why many ALS drugs fail as the disease progresses: the brain's pumps become more active and remove both toxins and medicine. Blocking these pumps improves drug efficacy in mouse models.
Researchers developed an anti-cancer drug that protects normal cells from radiation damage while sparing cancer cells. The compound, RTA 408, increases the effectiveness of radiation therapy in prostate cancer models and has potential applications for treating accidental radiation exposure.
Researchers have found that circulating tumor cells in the blood can accurately reflect the genetic status of metastatic breast cancer patients. This discovery could help guide treatment decisions and track patient progress without requiring repeat biopsies.
A team of researchers found nearly double the number of genomic loci that might be coding for transfer RNAs (tRNAs) in humans, with most resembling mitochondrial tRNAs. The discovery suggests unexpected new links between the human nuclear and mitochondrial genomes.
Researchers found that MRSA biofilms form in joint fluid, making infections resistant to antibiotics. Pre-treatment with an enzyme can inhibit biofilm formation and increase bacterial susceptibility to antibiotics.
Researchers have found that microRNA isoforms are more common than initially assumed, with certain variants exhibiting population-dependent and gender-dependent expression profiles. These findings suggest that miRNAs may serve a purpose beyond regulation of protein-coding genes.
Researchers at Thomas Jefferson University have discovered a novel approach to killing colon cancer cells by using an antibody that targets the GUCY2C receptor, which is over-produced and exhibited on the surface of cancer cells. The immunotoxin selectively destroys colon cancer cells while sparing surrounding tissue.
A new study published in Scientific Reports reveals that non-canonical microRNA binding is widespread, targeting both protein-coding genes and non-coding RNAs. This suggests a more complex role for microRNAs in regulating gene abundance levels.
A study at Thomas Jefferson University found that using hypertonic saline during and after complex Whipple surgery reduced overall complication rates by 25%. The increased salt concentration helps to reduce fluid buildup and swelling, promoting faster recovery with fewer complications.
Researchers found a 57% decrease in wound complications when sutured incisions were used compared to staple closure. Suturing takes 9 minutes longer to complete than stapling, but has a clear benefit for women.
Researchers at Thomas Jefferson University found that alcohol consumption leads to a buildup of fat in the lungs, weakening the immune system and increasing the risk of pneumonia and acute respiratory distress syndrome. This discovery offers a potential new explanation for why heavy drinkers are more susceptible to lung disease.
Researchers found that calorie restriction decreased microRNA production, which promotes the extracellular matrix and prevents cancer cells from spreading. The study aims to test whether calorie restriction can improve outcomes for women with breast cancer in a clinical trial.
A phase III clinical trial shows that non-invasive magnetic resonance guided focused ultrasound treatment relieves pain and improves function for most patients with bone metastases. Patients responded well to treatment, with 64 percent experiencing either no pain or a significant reduction in their pain within several days of treatment.
Researchers at Thomas Jefferson University found that a single cell type, T-helper cells, is actively suppressed in several experimental cancer vaccines. This discovery paves the way for methods to break suppression and improve cancer vaccine effectiveness.
Researchers found that mitochondria unable to self-repair are responsible for muscle weakness in both long-time alcoholics and patients with mitochondrial disease. The study identified a key protein, Mfn1, involved in skeletal muscle cell fusion.
Researchers discovered that antibiotics like gentamicin can cause abnormal proteins to be presented to the immune system, potentially triggering autoimmune disease. This approach, used to treat diseases in genes with truncated proteins, may come with a risk of initiating autoimmunity.
Researchers found that a vitamin A derivative, retinoic acid, can reverse the changes in pre-cancerous breast cells, making them resemble normal cells. However, this treatment has no effect on fully developed cancer cells. The study's findings suggest that there may be a narrow window of opportunity for this treatment to be effective.
Researchers at Jefferson Breast Care Center found that genomic tests like MammaPrint and BluePrint provide more accurate classification of breast cancer subtypes than traditional methods. These tests enable better identification of patients who benefit from chemotherapy, reducing unnecessary treatment risks.
Researchers found that cyclin D1 induces the processing of mature microRNA through Dicer, leading to reduced levels of miRNAs in certain cancers. This mechanism may contribute to the initiation and progression of aggressive basal-like breast cancer subtypes.
Researchers found that occupational therapy using sensory integration (OT-SI) provided better outcomes than standard care for children with autism. OT-SI therapy helps improve processing of sensation, leading to better participation in everyday activities.
A new rabies vaccine aims to develop a single dose contraceptive vaccine, reducing child deaths and controlling dog rabies. The vaccine targets dendritic cells to induce strong immune responses against rabies and foreign antigens.